Acute transient psychotic disorder
|
disease |
Pathological Conditions, Signs and Symptoms; Mental Disorders
|
Mental or Behavioral Dysfunction
|
4
|
9
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Charcot-Marie-Tooth disease, Type 2A
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
7
|
3
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Finger Agnosia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Finding
|
7
|
|
0.100 |
None |
|
0 |
|
|
|
Deposits immunoreactive to beta-amyloid protein
|
phenotype |
|
Finding
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Posterior cortical atrophy syndrome
|
disease |
|
Disease or Syndrome
|
12
|
8
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Abnormal social behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Finding
|
19
|
|
0.100 |
None |
|
0 |
|
|
|
Hyper LDL cholesterolaemia
|
disease |
|
Disease or Syndrome
|
20
|
19
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Semantic Dementia
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
20
|
4
|
0.100 |
None |
|
0 |
|
|
|
Primary Progressive Nonfluent Aphasia
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
21
|
13
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Neurofibrillary degeneration (morphologic abnormality)
|
phenotype |
|
Cell or Molecular Dysfunction
|
21
|
|
0.100 |
None |
|
0 |
|
|
|
Physiologic disinhibition
|
phenotype |
|
Organ or Tissue Function
|
23
|
|
0.100 |
None |
|
0 |
|
|
|
Dyslipoproteinemias
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
25
|
35
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Lipids measurement
|
group |
|
Laboratory Procedure
|
27
|
53
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Autoantibody measurement
|
phenotype |
|
Laboratory Procedure
|
27
|
52
|
0.100 |
None |
1.000 |
1 |
3
|
2009 |
2009 |
Behavioral variant of frontotemporal dementia
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
35
|
10
|
0.010 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Pseudocholinesterase Measurement
|
phenotype |
|
Laboratory Procedure
|
39
|
568
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Memory performance
|
phenotype |
|
Mental Process
|
40
|
71
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Dysgraphia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
43
|
2
|
0.100 |
None |
|
0 |
|
|
|
Longevity
|
phenotype |
|
Temporal Concept
|
48
|
74
|
0.100 |
None |
1.000 |
2 |
1
|
2011 |
2012 |
Cognitive changes
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
50
|
15
|
0.020 |
None |
0.500 |
2 |
|
2011 |
2019 |
Primary Progressive Aphasia (disorder)
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
51
|
11
|
0.010 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Polypoidal choroidal vasculopathy
|
disease |
|
Disease or Syndrome
|
56
|
67
|
0.010 |
None |
< 0.001 |
1 |
1
|
2013 |
2013 |
Social disinhibition
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
56
|
5
|
0.100 |
None |
|
0 |
|
|
|
Carotid Artery Diseases
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
69
|
6
|
0.010 |
None |
1.000 |
1 |
1
|
2009 |
2009 |